Different IVIG Glycoforms Affect In Vitro Inhibition of Anti-Ganglioside Antibody-Mediated Complement Deposition

• Makoto Sudo,

  Affiliation Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  ⨯
• Yoshiki Yamaguchi,

  Affiliation Structural Glycobiology Team, RIKEN, Wako, Saitama, Japan

  ⨯
• Peter J. Späth,

  Affiliation Institute of Pharmacology, University of Bern, Bern, Switzerland

  ⨯
• Kana Matsumoto-Morita,

  Affiliation Structural Glycobiology Team, RIKEN, Wako, Saitama, Japan

  ⨯
• Benjamin K. Ong,

  Affiliation Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  ⨯
• Nortina Shahrizaila,

  Affiliation Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

  ⨯
• Nobuhiro Yuki

  * E-mail: mdcyuki@nus.edu.sg

  Affiliations Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  ⨯